05/05/2023 | Jed Boye | 4 min read
Is Ozempic’s higher rates of diabetic retinopathy and adverse ocular events compared to other GLP-1 agonists cause for concern?
05/04/2023 | Blake Cooper | 10 min read
Why I support the off-label use of semaglutide for many indications – including weight loss
05/03/2023 | Jed Boye | 3 min read
We share some of the most interesting recent Retina research
05/02/2023 | Sarah Healey | 5 min read
Is OkuStim the future of retinitis pigmentosa treatment?
05/01/2023 | Sarah Healey | 6 min read
FDA approve new treatment for geographic atrophy
04/28/2023 | Jed Boye | 3 min read
We explore the most interesting anterior segment research
04/27/2023 | Sarah Healey | 4 min read
Improving translational models for inherited retinal diseases
04/26/2023 | Sarah Healey | 3 min read
EYLEA: The FDA approved VEGF inhibitor for ROP
04/26/2023 | Sponsored by Topcon Healthcare | 4 min read
Two ophthalmologists share how Topcon’s Triton OCT makes a difference in their clinics.
04/21/2023 | Jon Greenaway
Our image of the month, from the Ophthalmic Photographers Society
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Closing the Research Gap
One in Ten Million
The Ophthalmologist Power List 2023
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: